Dimitrios Syrengelas: Haemophilia Care Begins With Safe Movement
Dimitrios Syrengelas, PT Commitee Member at European Association for Haemophilia and Allied Disorders (EAHAD), shared a post on LinkedIn:
”A big thank you to Paula Loughnane for the interview and for such thoughtful and insightful questions.
It was a real pleasure discussing our study and, more importantly, the need to support safe movement and motor development in infants with haemophilia from the very beginning.
As we discussed: protecting a baby with haemophilia should not mean preventing that baby from moving.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”Physio News
Are infants with haemophilia getting enough opportunities to move, explore and develop from the very beginning?
In our latest podcast, Dimitrios Syrengelas and Paula Loughnane discuss the study ‘Haemophilia infants gross motor development: comparisons with full-term and preterm infants of the same nationality’, exploring gross motor development in infants with haemophilia using the Alberta Infant Motor Scale (AIMS).
Listen to the full conversation on Spotify.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC